Phentemine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes oxazepam. It belongs to anxiolytic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes oxeladine citrate. It belongs to antitussive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pancreatine. It belongs to digestive aid category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes paracetamol. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pentaerythritol tetranitrate (PETN). It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pentoxifyline. It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes phenylephrine HCI. It belongs to decongestant category. Bulk physical form: pellets, resinates, powder DC. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes phenylpropanolamine HCI. It belongs to decongestant / anorexic category. Bulk physical form: pellets, resinates. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes phenyltoloxamina citrate. It belongs to antihistaminic category. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pholedrine sulphate. It belongs to antihypotensive (circulatory stimulant) category. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pholedrine sulphate + norphenephrine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes piroxicam. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.